Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey. Show More...
-
Website https://www.integralife.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 11.10 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 1.08 0.47 0.72 -0.37 0.52 -0.05 0.94 0.82 0.72 0.58 0.31 Dividends USD Payout Ratio % * Shares Mil 60.0 59.0 57.0 58.0 66.0 71.0 79.0 79.0 84.0 86.0 86.0 Book Value Per Share * EUR 6.24 7.22 7.11 5.65 8.62 9.05 10.42 9.76 14.02 14.42 14.28 Free Cash Flow Per Share * EUR 1.18 0.7 0.53 -0.32 0.39 0.74 1.02 0.62 1.09 0.48 Return on Assets % 6.71 2.59 3.57 -1.44 2.45 -0.21 4.16 2.58 1.92 1.57 0.8 Financial Leverage (Average) 2.03 2.32 2.25 1.78 2.24 2.36 2.15 3.34 2.25 2.33 2.57 Return on Equity % 13.9 5.64 8.16 -2.86 4.95 -0.48 9.37 7.19 5.2 3.6 1.94 Return on Invested Capital % 9.25 6.01 5.61 -0.35 4.27 0.76 6.48 3.92 3.83 3.08 2.12 Interest Coverage 5.47 2.03 3.34 -0.25 2.96 3.58 4.5 1.33 1.89 2.11 1.8 Current Ratio 2.22 4.44 4.24 4.4 4.2 3.15 4.01 2.36 2.95 2.59 4.09 Quick Ratio 1.17 2.15 1.98 2.0 1.62 1.3 2.02 1.22 1.54 1.43 2.45 Debt/Equity 0.59 1.08 1.0 0.58 0.89 0.93 0.79 1.85 0.96 0.99 1.25